Following the retirement of Non-Executive Director Sue Wadsworth, the Isle of Wight NHS Trust, working with the Trust Development Authority (TDA), has moved quickly to fill this top level Board vacancy.
In addition to finding a replacement, The TDA have also reappointed Charles Rogers for a period of two years and extended the appointment of Danny Fisher for 6 months. The recruitment of a new Chairman will commence once the purdah period for the General Election comes to an end.
The Trusts third designate Non-Executive Director, who joined the Trust in January 2014, Jessamy Baird (pictured above), has now been appointed to into the full Non-Executive Director role left vacant with the retirement of Sue Wadsworth. The appointment takes effect from 1st April 2015 and runs to 31st March 2017.
Jessamy is Director, Market Access for Sanofi, a global integrated healthcare leader in pharmaceuticals, focused on patients’ needs. She has previously held Executive and Non-Executive positions in NHS Trusts as well as undertaking research into public health, general practice and health economics at a number of Universities. She lives in Whitchurch, Hampshire.
Commenting on her appointment Jessamy said:
“I have had a long term and deep interest in people who receive Community and Mental Health care and the pivotal role that ‘out of hospital’ care now plays in any health system. My career, whether in the public or private sector, has been focused on healthcare. Since joining the Trust in January 2014 I have enjoyed working with Trust staff and stakeholders. I believe I bring multiple perspectives to the Non-Executive Director role and look forward to continuing to work for the benefit of Island healthcare.”
The Trust Development Authority have also re-appointed Bembridge resident Charles Rogers as a Non-Executive Director for a period of two years from 29th July 2015 to 28th July 2017 and brings 25 years management experience to the local NHS and has particular skills and experience in operational management, strategic planning and change management.
“The NHS a vital service for all of us. It is highly regarded and valued by people on the Island and is our largest employer. It has a crucial role to play and although it performs extremely well there is a very challenging agenda ahead and there is always room for improvement. I look forward to continuing to play my part in that.”
Chairman of the Trust, Danny Fisher recently announced that after eight years as Chairman of the Trust and the predecessor Primary Care Trust he would be standing down. Appointments to the post are made by the Trust Development Authority (TDA) and to provide time for the recruitment of a new Chairman Mr Fisher’s appointment has been extended by the TDA for 6 months to 30th September 2015.
“Non-Executives in the NHS bring a different perspective and insight, together with essential skills developed outside the NHS. That has been very valuable in the past and I am sure will continue to be so. The appointment of Designate Non-Executive Directors enabled us to bring in additional expertise and I hope the Board is able to make similar appointments in future.”
The Trust Board now comprises:
Non-Executive Directors Executive Directors
· Danny Fisher, Chairman
· Dr Nina Moorman, Non-Executive Director
· Charles Rogers, Non-Executive Director
· Jane Tabor, Non-Executive Director
· David King, Non-Executive Director
· Jessamy Baird, Non-Executive Director
· Lizzie Peers, (Non-Voting) Non-Executive Financial Advisor to Trust Board · Karen Baker, Chief Executive
· Chris Palmer, Executive Director of Finance
· Dr Mark Pugh, Executive Medical Director
· Alan Sheward, Executive Director of Nursing and Workforce
· Katie Gray, Executive Director of Transformation and Integration
· Mark Price (Non-Voting), Company Secretary and Foundation Trust Programme Director.
More information about the Trust is available in the 2013/14 Annual Report which can be found on the Trust website at http://www.iow.nhs.uk/about-us/annual-report/annual-report.htm.